EVO News and Press, Evotec SE

Evotec Reports Results of the Annual General Meeting 2026 PR Newswire 11.06.2026 / 15:30 CET/CEST The issuer is solely responsible for the content of this announcement. All agenda items adopted Dieter Weinand and Dr. Wolfgang Hofmann newly elected to the Supervisory Board ...

HAMBURG, DE / ACCESS Newswire / June 2, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced the appointment of Rui Wang as Executive Vice President, Head of Global In Silico and AI. Mr. Wang brings to Evotec more than 20 years of experience supporting global pharma and ...

2026-05-12 17:49:15 ET More on Evotec SE Quant snapshot: Delta Air Lines leads top-rated names as Byrna Technologies, Simulations Plus lag Seeking Alpha’s Quant Rating on Evotec SE Read the full article on Seeking Alpha For further details see: Evo...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. HAMB...

2026-05-07 06:42:42 ET More on Jobs & Employment U.S. private sector adds 109K jobs in April, more than estimated: ADP jobs report Job openings fall less than feared in March, quits rate ticks up: JOLTS report A Robot Economy: Who Gets Rich, Who Gets Left Behind ...

2026-05-06 11:51:22 ET Evotec SE (EVO) Q1 2026 Earnings Call May 6, 2026 8:00 AM EDT Company Participants Sarah Fakih - Executive VP, Head of Global Communications & Investor Relations Christian Wojczewski - CEO & Chairperson of the Management Board Claire ...

Joint Evotec-Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelines Collaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D capabilities and Almirall's dermatology expertise HAMBURG, DE / ...

Grants support discovery and development of novel drug candidates and evaluation and prioritization of advanced drug regimens for clinical testing New funding from the Gates Foundation extends Evotec's commitment to create more effective tuberculosis treatment regimens HAMBURG, GERM...

Nomination of Dr. Wolfgang Hofmann as independent Supervisory Board member to further strengthen oversight and governance capabilities Conclusion of cooperation agreement with MAK Capital following constructive discussions, reflecting Evotec's commitment to open shareholder dialogue ...

HAMBURG, DE / ACCESS Newswire / April 29, 2026 / Evotec SE (NASDAQ:EVO; Frankfurt Prime Standard: EVT) will hold a webcast and conference call to announce its financial results for the first quarter 2026 and provide a business update on Wednesday, May 6, 2026. The conference call will be held ...